Commercial drug list important updates

Effective with dates of service on and after April 1, 2019, and in accordance with our Pharmacy and Therapeutic (P&T) process, we will update our commercial drug lists. Updates may include changes to drug tiers or the removal of a drug.

 

To help ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a preferred drug to patients currently using a non-preferred drug, if appropriate.

 

Please note, this update does not apply to the Select Drug List or drugs lists utilized by the Federal Employee Program (FEP).

 

To view a summary of changes, click here.